Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Cough Remedies Market

Cough Remedies Market Share

  • Report ID: GMI9224
  • Published Date: Apr 2024
  • Report Format: PDF

Cough Remedies Market Share

The cough remedies industry is characterized by the presence of several key players offering range of products spanning across different dosage and medication categories. Investments related to research and developments of products, strategic partnerships, mergers, and acquisitions are among the commonly employed strategies by players to expand their market presence and gain a competitive advantage.
 

Cough Remedies Market Companies

Prominent players operating in the cough remedies industry include:

  • AstraZeneca plc
  • Bayer AG
  • GSK plc
  • Johnson & Johnson
  • Novartis AG
  • Pfizer Inc.
  • Prestige Consumer Healthcare
  • Procter & Gamble
  • Reckitt Benckiser Group plc
  • Sun Pharmaceutical Industries Ltd
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of cough remedies reached USD 9.2 billion in 2023 and is set to witness 5.6% CAGR from 2024 to 2032, owing to growing prevalence of respiratory conditions and increasing air pollution levels.

The oral syrups segment accounted for 45.4% of the market share in 2023, due to personal preferences or ease of use.

North America market size was USD 3.4 billion in 2023 and is anticipated to grow at 5.1% CAGR between 2024 – 2032, attributed to urbanization, industrialization, and environmental pollution.

AstraZeneca plc, Bayer AG, GSK plc, Johnson & Johnson, Novartis AG, Pfizer Inc., Prestige Consumer Healthcare, Procter & Gamble, Reckitt Benckiser Group plc and Sun Pharmaceutical Industries Ltd.

Cough Remedies Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 10
  • Tables & Figures: 151
  • Countries covered: 23
  • Pages: 110
 Download Free Sample